Piermont Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Piermont Capital Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14,990	Closed	-$575K	–	187
2018 Q2	$575K	Sell	14,990 -1,300	-8%	-$43.8K	0.18%	139
2018 Q1	$549K	Sell	16,290 -1,380	-8%	-$53K	0.18%	147
2017 Q4	$785K	Sell	17,670 -550	-3%	-$25.1K	0.26%	121
2017 Q3	$913K	Sell	18,220 -16,709	-48%	-$854K	0.3%	116
2017 Q2	$1.84M	Buy	34,929 +2,269	+7%	+$122K	0.53%	72
2017 Q1	$1.81M	Sell	32,660 -290	-0.9%	-$16K	0.43%	98
2016 Q4	$1.72M	Buy	32,950 +6,710	+26%	+$324K	0.39%	105
2016 Q3	$1.27M	Buy	26,240 +9,680	+58%	+$490K	0.3%	129
2016 Q2	$917K	Buy	16,560 +7,940	+92%	+$437K	0.24%	168
2016 Q1	$460K	Buy	+8,620	New	+$425K	0.15%	159
2014 Q1	–	Sell	-5,680	Closed	-$203K	–	159
2013 Q4	$203K	Buy	+5,680	New	+$189K	0.1%	120

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Piermont Capital Management's PBH Position: Q3 2018 in Review

Piermont Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2018, closing a stake of 14,990 shares — an estimated $575K sold.

Piermont Capital Management first reported a position in PBH in Q4 2013 and held it in 11 quarters. The position peaked at $1.84M in Q2 2017. 237 funds tracked by Wall St. Rank hold PBH as of Q3 2018.

Piermont Capital Management reported no remaining Prestige Consumer Healthcare position as of Q3 2018 after selling out during the quarter.
Piermont Capital Management sold 14,990 Prestige Consumer Healthcare shares in Q3 2018, an estimated $575K.
Piermont Capital Management first reported a position in Prestige Consumer Healthcare in Q4 2013 and held it in 11 quarters.
Piermont Capital Management's Prestige Consumer Healthcare position peaked at $1.84M in Q2 2017.
237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2018.

Based on Piermont Capital Management's 13F filing for Q3 2018, filed 6 Nov 2018.